Recently, Taizhou Zecen Biotech Co., Ltd. Has acquired 58 pcs of Class II medical devices (in vitro diagnostic reagents) registration certificate issued by the provincial Food and Drug Administration. At present, the enterprise already has 113 registration certificates for the Class II in vitro diagnostic reagents, which is further speeding up the industrialization process.
Direct branch has always been adhering to the working principle of "No Dropping the Standards; No Reducing the Procedures; Optimizing the Process; Speeding Up" to provide full and all-round professional guidance and tracking services to improve the registration quality and to shorten the time of obtaining registration certificates. At the same time, to guide enterprises to continuously improve product quality standards, and to promote product quality to a new level as to further enhance the industry's influence of China Medical City in vitro diagnostic reagent enterprises; to seize the opportunity of conducting joint research and preparation of national standards with National Institute of Food and Drug; To actively recommend 11 in-vitro diagnostic reagents enterprises including Taizhou Zecen to participate in work of research and development.
Until the end of November 2017, the industrial park have received a total of 419 registration certificate for in vitro diagnostic reagents, including 284 registration certificates for Class II and Class III products. The number of in-vitro diagnostic reagents enterprises and certified products in the park has increased rapidly, and the industrial agglomeration effect was further highlighted.